Best Health Care Grants in Wisconsin

The ALF: Pilot Research Awards offer funding of $50,000 for one year to early career investigators focusing on innovative research in rare liver diseases. These awards aim to support junior faculty during the pilot phase of their projects, encouraging high-risk, high-reward ideas. Proposals should present clear, testable hypotheses without the need for extensive preliminary data, ultimately aiming to generate key findings that can lead to larger NIH grants.

The Junior Faculty Development Award, funded by the American College of Gastroenterology, offers $450,000 over three years to support junior researchers in gastroenterology or hepatology. Aimed at ACG members, this award allows recipients to dedicate 50% of their time to clinical research, enhancing their skills and advancing their careers. Eligible candidates include those within seven years post-fellowship who can guarantee protected research time. The initiative fosters novel research that directly impacts gastrointestinal health.

The Established Investigator Bridge Funding Award, supported by the ACG Institute for Clinical Research and Education and the American College of Gastroenterology, offers $300,000 in funding over two years for established researchers facing funding gaps. Designed for clinical gastroenterology and hepatology, this grant aims to sustain impactful research programs during federal funding lapses. Eligible applicants must be ACG members and have at least eight years of experience post-training, along with a proven track record of federal funding in relevant fields.

The Puffin Foundation's Environmental Artistic Activism Grant Program supports artists addressing environmental issues through diverse artistic genres such as film, music, and theater. Grants, typically around $1,750, fund projects that prioritize sustainability and innovative solutions to the climate crisis. Eligible applicants include U.S. citizens, permanent residents, and current DACA recipients. The foundation emphasizes projects that avoid contributing to environmental harm while fostering artistic expression and community engagement.

The NIMH Career Transition Award (K22) supports tenure-track intramural investigators at NIMH in their transition to independent research faculty positions. This program aims to foster innovative research in mental health, encouraging applicants with a strong record of research excellence. Key deadlines for applications vary, including those for standard and renewal submissions, emphasizing the importance of timely applications to secure funding and advance mental health research initiatives.

The Interventions to Reduce Sleep Health Disparities (R01) grant aims to fund non-pharmacological strategies that enhance sleep health and address disparities in sleep among affected populations. The program emphasizes innovative approaches to examine sleep as a crucial element in mitigating health disparities across various health outcomes. Deadlines for applications range from February 2025 to June 2027, supporting both standard and renewal submissions under the National Institutes of Health.

The Research Enhancement Award Program (REAP) aims to boost basic and clinical research at health professional and graduate schools that have historically received limited NIH funding. By supporting small-scale research projects led by faculty, REAP fosters student engagement in significant research endeavors, enhancing their educational experience. Eligible institutions must grant advanced degrees in health professions and have received under $6 million in NIH support in four of the last seven years, promoting broader participation in the nation's biomedical research efforts.

The Tribal Agriculture Fellowship supports career and technical education students in agriculture, focusing on Native American, Alaska Native, and Native Hawaiian individuals. This last-dollar fellowship aims to fill financial gaps, allowing students to prioritize their education while participating in developmental activities. Eligible students must maintain academic progress and engage in community support initiatives. The fellowship provides resources for tuition, housing, and professional development over up to four years, promoting agricultural knowledge in tribal communities.

The Klingenstein-Simons Fellowship Awards in Neuroscience support early-career investigators conducting basic or clinical research focused on neurological and psychiatric disorders. Awardees receive $150,000 annually for three years, aimed at fostering innovative research that contributes to understanding and treating these disorders. The fellowship encourages applications from underrepresented groups and prioritizes candidates with promising scientific careers who may not have received substantial prior funding, promoting collaboration and mentorship in the neuroscience community.

The CLRA Research Grant Program, led by the Children’s Leukemia Research Association, focuses on funding innovative research aimed at uncovering the causes of leukemia and improving treatment options. Grants totaling $30,000 are awarded to U.S.-based researchers, with the intention of advancing scientific understanding and ultimately finding a cure. The program has made significant contributions to the high cure rates for childhood leukemia, showcasing the importance of continued research in this field.

This funding opportunity encourages applications for clinical observational studies focused on musculoskeletal, rheumatic, and skin diseases. It aims to gather essential data for designing future clinical studies, enhancing understanding of disease symptoms, progression, and patient outcomes. Observational studies supported by this initiative will contribute to the development of objective biomarkers and effective outcome measures. Applicants are invited to address key challenges in clinical project design, ensuring a robust foundation for subsequent clinical trials.

The Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) aim to support clinical trials that can be completed within a limited timeframe. This funding opportunity encourages a variety of exploratory studies that align with the NIAMS mission, focusing on interventions such as drugs, biologics, devices, and various therapies. Applications are due by 5:00 PM local time of the applicant organization.

The Fred and Barbara Erb Family Foundation is dedicated to fostering a healthy Great Lakes ecosystem and a vibrant Southeast Michigan community. Since its inception, it has invested over $180 million in environmental, cultural, and educational initiatives. As it transitions to spend down its assets by 2034, the Foundation aims to make bold, impactful investments that address urgent community needs and promote sustainable development.

The Ono Initiative Grant by the Ono Pharma Foundation supports innovative research in Chemical Biology, aiming to transform human health. It welcomes proposals from Principal Investigators (PIs) at nominated institutions, focusing on groundbreaking solutions and promoting the development of young scientists. Grants of up to $1,035,000 over three years are available, fostering collaboration and transformative research aligned with the foundation's mission.

The Patterson Foundation Scholarship offers $4,750 annually to children and legal dependents, aged 24 and under, of full-time employees at Patterson Companies in the U.S., U.K., and Canada. Renewable for up to four years, this scholarship can total $19,000 for higher education at accredited institutions. All undergraduate degrees are eligible, and students can reapply even if they have previously been denied. A selection committee from Scholarship America, Inc. reviews applications each summer.

The Limited Competition K12 Mentored Research Career Development Program aims to support institutions in developing innovative career pathways for later-stage postdoctoral fellows and junior faculty. This initiative encourages applicants from those with existing Clinical and Translational Science Awards (CTSA) to foster independent research careers. By creating diverse opportunities across academia, industry, and government, the program enhances engagement in clinical and translational science research, ultimately contributing to significant advancements in health outcomes.

U.S. Writers Aid Initiative

PEN America is an organization of writers and their allies, and that solidarity is never more important than when members of our literary community face crises. PEN America’s U.S. Writers Aid Initiative, part of the PEN America Writers Emergency Fund, offers grants for writers in the United States facing acute financial need following an emergency situation.

The U.S. Writers Aid Initiative is intended to assist fiction and nonfiction authors, poets, playwrights, translators, and journalists in addressing short-term financial emergencies. To be eligible, applicants must be professional writers based in the United States, and be able to demonstrate that this one-time grant will be meaningful in helping address a short-term emergency situation. The fund is limited, and not every application can be supported.

Grant decisions are made on a quarterly basis by a volunteer committee of literary peers in consultation with PEN America staff, using the following guidelines to evaluate professional credentials:

• Publication of one or more books. (Writers who are only self-published or published by a press that charges for publication are not eligible.)
• Multiple essays, short stories, or poems appearing in literary anthologies or literary journals (either online or in print) in the last two years.
• A full-length play, performed in a theater by a professional theater company. Productions in academic settings qualify if the author is not a student at the time of the production.
• Employment as a full-time professional journalist, columnist, or critic, or a record of consistent publication on a freelance basis in a range of outlets during the last two years.
• Contracted forthcoming books, essays, short stories, poems, or articles for which the name of the publisher can be provided.
• Other qualifications that support the applicant’s professional identity as a writer.

The AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer provides $100,000 annually for three years to early-career faculty in digestive disease research. This award aims to support independent careers in pancreatic cancer research by protecting a significant portion of the recipient's time for research activities. Eligible applicants must hold an MD, PhD, or equivalent and work at a North American institution, with AGA membership required. Strong encouragement is given to underrepresented groups.

The AGA-Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer provides $100,000 annually for three years to early-career faculty focused on independent research in pancreatic cancer. This award aims to protect at least 50% of the recipient's time for research activities. Eligible applicants must hold an MD or PhD and be classified as early-career. The award encourages physician-scientists and underrepresented groups in biomedical research to apply, supporting innovative research that can lead to significant advancements in understanding pancreatic cancer.

The AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award provides $100,000 annually for three years to early-career faculty dedicated to gastric cancer research. Eligible candidates must have an MD, PhD, or equivalent and a full-time faculty position in North America. The award supports research in various areas related to gastric cancer, ensuring a minimum of 50% time commitment to the project, thus fostering independent careers in digestive diseases.

The American Diabetes Association's Postdoctoral Fellowship Awards aim to foster emerging leaders in diabetes research. With a focus on innovative research, these fellowships provide up to three years of funding, including a stipend and allowances. Eligible applicants must hold a recent advanced degree and conduct research at U.S. affiliated institutions. This initiative not only supports career development but also contributes significantly to the mission of preventing and curing diabetes.

The Zuckerman Postdoctoral Scholars Program fosters collaboration between leading scientific institutions in the U.S. and Israel by attracting top postdoctoral researchers. With a focus on STEM leadership, this program offers a unique two-year scholarship, allowing scholars to conduct research at participating Israeli universities and North American institutions. The initiative aims to strengthen academic ties, enhance research capabilities, and support the return of talented Israeli scholars to their home institutions, ultimately enriching the global scientific community.

The Tides Stronger Together Fund, under the Tides Foundation, provides essential support grants to fiscally sponsored partners focused on historically underserved communities. By building organizational capacity and leadership, the fund empowers community changemakers to address inequities and enhance sustainability. With a pooled funding model, it directly responds to the needs of over 120 partners, ensuring resources are effectively allocated where they are most impactful, ultimately fostering long-term community resilience.

The Stimulating Hematology Investigation: New Endeavors (SHINE) program aims to enhance nonmalignant hematology research aligned with the goals of the NIDDK, NIA, and NHLBI. It invites R01 grant applications focused on innovative and early translational hematology topics, fostering growth in this critical research area. Key deadlines for applications span from February 2025 to October 2027, allowing for both standard and renewal submissions.

The NIA Academic Leadership Career Award (K07) provides funding for established investigators to strengthen research capacity in aging and Alzheimer's Disease. The program supports the development of educational infrastructure, mentorship, and career development activities. Key deadlines for applications include February 12, June 12, and October 12 from 2025 to 2027. This award is specifically for research not involving independent clinical trials, allowing applicants to gain experience in trials led by others.

The Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) aims to enhance cancer treatment by integrating imaging and liquid biopsy assays. This initiative, led by the National Cancer Institute (NCI), encourages grant applications focused on assessing therapy responses and resistance emergence in patients. Key deadlines for submissions span from February 2025 to January 2028, providing ample opportunities for researchers to contribute to this vital area of cancer research.

This funding opportunity invites applications for R01 grants focused on molecular imaging methods to explore cancer inflammation in vivo. It aims to enhance understanding of dynamic interactions between inflammation and cancer through innovative imaging techniques. The initiative encourages collaborations between cancer researchers and imaging scientists to leverage molecular imaging for identifying cellular physiology changes in response to treatment. Deadline dates for applications range from February 2025 to October 2027, emphasizing timely submission for prospective researchers.